Laura Cufaro SRL
Laura Cufaro reported total assets of 145,385 € at the end of the 2025 financial year (annual accounts filed with the NBB on 10 Jun 2026).
The score of Laura Cufaro shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +148 % Total assets +58 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Laura Cufaro's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 46,143 € | ||||
| Equity | 135,568 € | ||||
| Cash | 134,485 € | ||||
| EBITDA | 66,837 € | ||||
| Total assets | 145,385 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Jun 2026
- Year ended 31 Dec 2024filed on 13 Jun 2025
- Year ended 31 Dec 2023filed on 14 Jun 2024
- Year ended 31 Dec 2022filed on 16 Jun 2023
- Year ended 31 Dec 2021filed on 01 Jul 2022
Laura Cufaro's financial analysis
- Solvency93.2%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Laura Cufaro
Laura Cufaro's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0738.700.233
- VAT number
- BE0738700233
- Peppol
- Registered · 0208:0738700233 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 03 Dec 2019
- Registered office
- 4480 Engis
- Latest accounts
- 2025 · filed on 10 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Laura Cufaro (SRL) has been based in Engis since 2019, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 46,143 € and equity of 135,568 €; its revenue is not published. Its solvency stands at 93.2%, above the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Laura Cufaro
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie de Bousval Retail sale of pharmaceutical products Genappe · balance sheet 139,616 €
- Apotheek Houben - Swinnen Retail sale of pharmaceutical products Genk · balance sheet 145,008 €
- Jetpharma Retail sale of pharmaceutical products Jette · balance sheet 146,419 €
- Pharmattou Retail sale of pharmaceutical products Asse · balance sheet 146,566 €
- Louka Services Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet 146,913 €
- Genaphar Retail sale of pharmaceutical products Brussels · balance sheet 147,330 €
- X - Pharma Retail sale of pharmaceutical products Verviers · balance sheet 150,150 €
- Un Coquelicot Orange Retail sale of pharmaceutical products Courcelles · balance sheet 150,628 €
Frequently asked questions about Laura Cufaro
What is the revenue of Laura Cufaro?
Laura Cufaro files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Laura Cufaro?
In Belgium, the VAT number is the company number prefixed with BE: BE0738700233 for Laura Cufaro, if the company is VAT-registered. Its company number (CBE) is 0738.700.233.
Where is the registered office of Laura Cufaro?
According to the CBE register, the registered office of Laura Cufaro is in 4480 Engis.
What is the equity of Laura Cufaro?
At the close of the 2025 financial year, the equity of Laura Cufaro amounts to 135,568 €, a solvency of 93.2% of total assets.
Who manages Laura Cufaro?
The register lists 1 active mandates at Laura Cufaro. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Laura Cufaro
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →